Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

The current gold standard in cancer diagnostics are biopsies from suspect tissue, which are examined using histology.

It is hoped that being able to diagnose the disease faster will also lead to the development of new treatment methods for aging societies.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer

Point-of-care devices, which are small automated instruments, are capable of performing diagnostics in decentralized locations

Blood clots in patients with medical issues, such as mechanical heart valves or other heart conditions, can lead to a stroke or heart attack

A portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.

Penn State researchers developed a prototype of a wearable, noninvasive glucose sensor.

Researchers are constantly working toward developing the best possible treatments for cancer. One area of interest is immunotherapy.

Researchers have developed a new blood-clotting test that uses only a single drop of blood and a smartphone vibration motor and camera.

A new wearable device created by Penn State researchers, is a less intrusive glucose monitor and could become the norm in diabetes care.

The test is inexpensive and uses a test strip and a small cube-shaped 1.6-inch reader to quantify a marker of prostate cancer.